Rare Cancers Genomics retweeted
New lungNENomics study: four molecular groups in lung neuroendocrine tumours, including supra-carcinoids.
Similar-looking tumours can follow different paths.
Congratulations @LexiLou_06 @EMathian @nl_alcala
@IARCWHO @CancersRare @CureNETs @ENETS_ORG
doi.org/10.1186/s12943-026-0…
Rare Cancers Genomics retweeted
Are lung #Neuroendocrine #Tumor actually four different diseases with unique evolutionary trajectories? Checkout our latest article in #MolecularCancer link.springer.com/article/10… @EmilieMathian @digenoma @m_foll @CancersRare funded by @CureNETs
We are thrilled to welcome Yuliya Lim as a PhD student in the team, under the supervision of @nl_alcala, L. Fernandez-Cuesta, and @m_foll! Yuliya recieved a competitive PhD fellowship from @laliguecancer and will work on deciphering the mysteries of cancer ecosystem complexity.
Rare Cancers Genomics retweeted
Very happy to share our latest work on pulmonary carcinoids published in @JCO_ASCO:
TERT Expression and Clinical Outcome in Pulmonary Carcinoids ascopubs.org/doi/10.1200/JCO…
Thanks to all involved!
@sfb1399 @DTG_Cologne @UKKoeln @charlesrudin @natasharekhtman @m_foll @digenoma
Rare Cancers Genomics retweeted
Congrats to @EmilieMathian, the @CancersRare team and a stellar team of expert pathologists who teamed up to advance the diagnosis of lung #neuroendocrine #tumors with emerging markers and #deeplearning 👏 sciencedirect.com/science/ar… @ESMO_Open
Rare Cancers Genomics retweeted
Thank you #ENETS24 for this award! @TheCleversLab @_Hubrecht @CancersRare @UMCU_Intl @NKI_nl @MaastrichtUMC @EMBLBarcelona
@nl_alcala @m_foll @FCLynnette @DerksJules
👀 🧵about our work teapawt.org/TalyaDayton/status/174… & preview cell.com/cancer-cell/abstrac… by @scgerstberger @KarunaMDPhD
Congratulations to @CureNETs funded researcher, @TalyaDayton for winning the ENETS award for best basic science paper! @embl #neuroendocrinecancer
Rare Cancers Genomics retweeted
Another rare cancer Data Note from @m_foll and the @IARCWHO Rare Cancers Genomics initiative, this time presenting PDTO data.
Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms doi.org/10.1093/gigascience/…
Rare Cancers Genomics retweeted
Replying to @m_foll
@m_foll presenting a new tool to learn about rare cancers
🔸 “reuse” data from EPIC study
🔸data about risk, exposure and lifestyle factors available
🔸 updated survival available soon
Waiting to make tool publicly available
#ESMOSarcomaAndRareCancers24 @myESMO
Rare Cancers Genomics retweeted
#RareDiseaseDay
At IARC, the Rare Cancers Genomics Team @CancersRare leads projects to study rare cancers.
An example is the lungNENomics project, which aims to improve diagnosis & management of lung neuroendocrine tumours.
More📄iarc.who.int/news-events/rar…
📺youtube.com/watch?v=5dLOA7Cj…
It is still time to apply if you are looking for a postdoc on single-cell and spatial omics in cancer! rarecancersgenomics.com/vaca…
🧬 Postdoc in the Rare Cancers Genomics team @IARCWHO 🇺🇳 Lyon 🇫🇷
Embark on a mission to decode the complexities of rare cancers and fight against a significant health challenge using state-of-the-art 'omics technology.
#SingleCell #SpatialOmics #PostdocJobs
🧵1/4
Rare Cancers Genomics retweeted
Dr. @nl_alcala is a scientist with @IARC. This is his first NETRF award: "Because each NET subtype carries specific DNA alterations and seems to make the immune system react differently, we believe that the interaction between tumor DNA and immune cells (1/3)
So grateful for the continuous support from @CureNETs!
We are thrilled to announce our newest NET research grant recipients. With representation from the US, Canada, France, Spain, Sweden & Germany, this impressive group of scientists truly highlights the global reach and impact of NETRF funded research. More: bit.ly/3Ou2OVp
Rare Cancers Genomics retweeted
We’re delighted that IARC’s Dr Nicolas Alcala @nl_alcala is among recipients of the Neuroendocrine Tumor Research Foundation’s @CureNETS newest neuroendocrine tumor (NET) research grants to investigators studying the most promising approaches to understanding & treating NETs!
We are thrilled to announce our newest NET research grant recipients. With representation from the US, Canada, France, Spain, Sweden & Germany, this impressive group of scientists truly highlights the global reach and impact of NETRF funded research. More: bit.ly/3Ou2OVp
Rare Cancers Genomics retweeted
Our paper on patient-derived tumor #organoids of #neuroendocrine neoplasms was published in the Dec2023 issue of @CancerCell!
@TheCleversLab @HansClevers @CancersRare @UMCU_Intl @NKI_nl @MaastrichtUMC @CureNETs
A belated 🧵
HNY everyone!
cell.com/cancer-cell/fulltex… /1
How to best finish 2023? With the talented @EMathian successfully defending her PhD @IARCWHO supervised by @m_foll @FCLynnette and @limingchen69! The next generation of researchers dedicated to @CureNETs is ready!
Rare Cancers Genomics retweeted
NEN in a dish: A patient-derived organoid biobank illuminates potential novel therapeutic opportunities for neuroendocrine neoplasms dlvr.it/T0BlkS
Rare Cancers Genomics retweeted
New @Cancer_Cell: @CancersRare @IARCWHO team up with @TalyaDayton @EMBLBarcelona to create mini-tumors of rare @cancers. A story of #biotechnology🥼🔬 & #conservation🐨, where we monitor #tumors like endangered species and witness #evolution in action cell.com/cancer-cell/fulltex… 🧵
Rare Cancers Genomics retweeted
Replying to @TheCleversLab
@TheCleversLab and the @CancersRare Team (IARC/WHO) developed the first organoid model for neuroendocrine tumors. During the development of this new model, they already discovered a potential new treatment for pulmonary NETs: hubrecht.eu/nets. @TalyaDayton @nl_alcala
Rare Cancers Genomics retweeted
Researchers from IARC and @_Hubrecht have created “mini-tumours” of a rare cancer that affects neuroendocrine cells. They are a powerful #tool to investigate how cancer develops in these cells, and how it may be managed in the clinic.
👉See more: iarc.who.int/news-events/res…
Lucky to have the super talented @A_SextonOates in the team! Congrats and well deserved!
Happy #ECSAday! Yesterday @ECSA_IARC hosted their annual Scientific Day, showcasing all the incredible research of our PhD students and postdocs. 🔬📊🧑🔬️
Congratulations to Maxime Bonjour, @A_SextonOates, and @harewoodr, who took home prizes for best presentations! 🏅🏅🏅






























